RXMD Therapeutics

RXMD Therapeutics is a Florida-incorporated subsidiary associated with Progressive Care that was formed in 2019 to develop and market cannabinoid-based and alternative nutraceutical products. Public disclosures describe the unit as focused on proprietary consumer-oriented products such as tinctures, skin creams, roll-ons, and gel capsules rather than a traditional clinical-stage drug pipeline. The entity appears to remain an active legal subsidiary within the broader corporate structure, but there is limited recent public evidence of an independently operating branded business, clinical development activity, or material standalone revenue disclosure. As a result, it is best characterized as a health-related consumer therapeutics/nutraceutical subsidiary rather than a conventional biotech or pharma company.